Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis

Amyloid

Volumn 18, Issue 4, 2011, Pages 211-215

  Ikeda, Shu Ichi ^a   Sekijima, Yoshiki ^a   Tojo, Kana ^a   Koyama, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloid; Cardiac amyloidosis; Senile amyloidosis; Transthyretin

Indexed keywords

AMYLOID; PREALBUMIN;

ABDOMINAL FAT ASPIRATION BIOPSY; AGED; AMYLOIDOSIS; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; MALE; PATIENT SAFETY; PRIORITY JOURNAL; SENILE AMYLOIDOSIS; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY;

ABDOMINAL FAT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; BIOPSY; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREALBUMIN; SERUM AMYLOID A PROTEIN; STROKE VOLUME; VENTRICULAR SEPTUM;

EID: 81255201276     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.623199     Document Type: Article

References (26)

1. Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: Clinical and genetic heterogeneity. Neurology 2002;58:1001-1007. (Pubitemid 34298536)
2. Westermark P, Bergstrom J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: Clinicopathologic and structural considerations. Amyloid 2003;10 Suppl 1:48-54. (Pubitemid 37372567)
3. Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-623. (Pubitemid 13012155)
4. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843-2845.
5. Piper C, Butz T, Farr M, Faber L, Oldenburg O, Horstkotte D. How to diagnose cardiac amyloidosis early: Impact of ECG, tissue Doppler echocardiography, and myocardial biopsy. Amyloid 2010;17:1-9.
6. Ikeda S. Cardiac amyloidosis: Heterogenous pathogenic backgrounds. Intern Med 2004;43:1107-1114. (Pubitemid 40074144)
7. Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981;63:188-196. (Pubitemid 11213350)
8. Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 1982;103:468-473. (Pubitemid 13137994)
9. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li YF, Masuda Y, Ikeda S. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid 1999;6:282-288. (Pubitemid 30004457)
10. Ishii W, Matsuda M, Nakamura N, Katsumata S, Toriumi H, Suzuki A, Ikeda S. Phenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritis. Intern Med 2003;42:400-405. (Pubitemid 36701562)
11. Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, et al. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001;51:264-270. (Pubitemid 32472697)
12. Maruyama K, Ikeda S, Yanagisawa N, Nakazato M. Diagnostic value of abdominal fat tissue aspirate in familial amyloid polyneuropathy. J Neurol Sci 1987;81:11-18. (Pubitemid 17140512)
13. Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in α2-macroglobulin and tau: A population-based autopsy study. Ann Med 2008;40: 232-239. (Pubitemid 351482541)
14. Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101:395-400. (Pubitemid 26392857)
15. Yamano M, Azuma A, Yazaki M, Ikeda S, Sawada T, Matsubara H. Early cardiac involvement in senile systemic amyloidosis: A case report. Amyloid 2008;15:54-59. (Pubitemid 351238492)
16. Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med 1983;143:1549-1552. (Pubitemid 13033756)
17. Rubinow A, Cohen AS. Skin involvement in familial amyloidotic polyneuropathy. Neurology 1981;31:1341-1345. (Pubitemid 11026859)
18. Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med 1973;132:522-523.
19. van Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 2006;54:2015-2021. (Pubitemid 43877954)
20. Pitkanen P, Westermark P, Cornwell GG 3rd. Senile systemic amyloidosis. Am J Pathol 1984;117:391-399. (Pubitemid 15182480)
21. Ikeda S, Tojo K, Suzuki-Tsuchiya A, Akamatu T, Hashimoto T, Higuchi K. Significant deposition of wild type transthyretin-derived amyloid in the gastrointestinal tract of aged individuals. Amyloid 2009;16:174-177.
22. Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 2008;14:3219-3230.
23. Tojo K, Sekijima Y, Kelly JW, Ikeda S. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis. Neurosci Res 2006;56:441-449. (Pubitemid 44755449)
24. Coelho T, Maia L, Martins da Silva A, Waddingtion-Cruz M, Plante-Bordeneuve V, Lozeron P, Suhr OB et al. Tafamidis (Fx-1006A): A first-in-class disease-modifying therapy for transthyretin familial amyloidosis (Abstract). Amyloid 2010;17(Suppl 1):75.
25. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. The Criteria Committee of the New York Heart Association, 1994.
26. Ikeda S, Yanagisawa N, Allsop D, Glenner GG. Evidence of amyloid β-protein immunoreactive early plaque lesions in Down's syndrome brains. Lab Invest 1989;61:133-137. (Pubitemid 19203861)